BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy

AMPA receptors as a molecular target in epilepsy therapy

(2013) M. A. Rogawski   ACTA NEUROLOGICA SCANDINAVICA

Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist

(2013) M. A. Rogawski et al.   ACTA NEUROLOGICA SCANDINAVICA

Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies

(2013) Bernhard J. Steinhoff et al.   EPILEPSIA

AMPA Receptor Properties are Modulated in the Early Stages Following Pilocarpine-induced Status Epilepticus

(2013) Isabella Russo et al.   NEUROMOLECULAR MEDICINE

Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus

(2012) Karthik Rajasekaran et al.   ANNALS OF NEUROLOGY

Emerging drugs for focal epilepsy

(2012) Marco Mula   EXPERT OPINION ON EMERGING DRUGS

Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity

(2011) Manuel Koller et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Rational polytherapy

(2009) Jacqueline A. French et al.   EPILEPSIA

Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: Systematic review and meta-analysis

(2009) Stefan Beyenburg et al.   EPILEPSIA